/   Home   /   Newsroom   /   Research News

Bromodeoxyuridine Enables Full-chemical Induction of Mouse Pluripotent Stem Cells

Aug 19, 2015     Email"> PrintText Size

The induced pluripotent stem cells (iPSCs) resemble embryonic stem cells (ESCs) and are considered as a prominent source for cell replacement therapy and drug screening. Much effort has been made to make iPSCs more amendable in clinical applications by using non-integrating gene delivery approaches or cell membrane permeable proteins to induce the reprogramming. Small molecule compounds have been found which are extremely useful in facilitating iPSC generation and replacing several reprogramming factors. However, full-chemical mediated reprogramming of somatic cells into pluripotent state is extremely difficult.

Prof. XIE Xin’s group from Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences has established a 96-well-plate-based chemical screening system for OSKM-induced reprogramming in mouse embryonic fibroblasts (MEFs). They identified that LiCl and high osmotic pressure enhances transcription factor-mediated reprogramming.

The researchers recently discovered that the commonly used biological reagent bromodeoxyuridine (BrdU) can enhance Yamanaka factor-mediated reprogramming and BrdU can replace Oct4, the most critical factor in iPSC generation. Further studies demonstrate that BrdU enables full-chemical induction of mouse iPSCs (CiPSCs) with several chemical cocktails, and the minimal combination is BrdU, CHIR99021, Repsox, and Forskolin. The CiPSCs resemble ESCs in terms of their gene expression, epigenetic status, in vivo differentiation and chimera generation.

Although the mechanisms underlying BrdU-mediated reprogramming remain to be elucidated, this combination lays a foundation for full-chemical induction of human iPSCs and provides a safer strategy to generate clinically applicable iPSCs. This study was recently published online in Cell Research.

This work was supported by the Chinese Academy of Sciences, the Ministry of Science and Technology of China, and the National Natural Science Foundation of China.

 

Figure: BrdU promotes full-chenmical induced reprogramming of MEFs. (Image by SIMM)  

Attachment:

(Editor: CHEN Na)

Contact

Related Articles

hepatocyte;hepatic transdifferentiation;chemical cocktail

Chemical Cocktails Promote Hepatic Reprogramming with a Single Transcription Factor

Aug 07, 2017

Recently, Prof. XIE Xin's group discovered that a chemical cocktail (including six small molecules) can promote the reprogramming of mouse fibroblast into hepatocyte-like cells (iHeps) with only one TF (Foxa1, Foxa2 or Foxa3). These iHeps showed...

stem cell;Parkinson’s disease;ZHOU Qi

Trials of Embryonic Stem Cells to Launch in China

May 31, 2017

Qi Zhou, a stem-cell specialist at the Chinese Academy of Sciences Institute of Zoology in Beijing, is leading both efforts. For the Parkinson’s trial, his team assessed hundreds of candidates and have so far have picked ten who best match the ES cells in the cell bank, ...

Contact Us

Copyright © 2002 - 2017 Chinese Academy of Sciences